Skip to main content

Table 2 Univariate Survival Analysis According To Clinical Characteristics

From: Fibrinogen: a novel predictor of responsiveness in metastatic melanoma patients treated with bio-chemotherapy: IMI (italian melanoma inter-group) trial

Clinical Variable

No. Of patients

Median Survival, Months (CI)

Odds Ratio

Log-Rank P

Liver Disease

    

   Yes

114

12 (9.7–14.6)

2.4 (1.64–3.53)

 

   No

62

6.3 (4.8–8.6)

 

0.0001

PS

    

   0

119

1.6 (9.2–14.4)

1.85 (1.27–2.67)

0.001

   1–2

57

6.9 (4.7–10.1)

  

Age

    

   <60 years

99

9.2 (7.3–12.7)

0.97 (0.7–1.4)

0.85

   ≥ 60 years

77

10.7 (8.2–13.2)

  

Sex

    

   Male

105

9.3 (7.8–11)

0.78 (0.54–1.12)

0.178

   Female

71

12 (7.9–14.6)

 Â